Development of anaplastic lymphoma kinase (ALK) inhibitors and molecular diagnosis in ALK rearrangement-positive lung cancer
Isamu Okamoto(Kyushu University), Yoichi Nakanishi(RIKEN Center for Integrative Medical Sciences)
Cited by 35
Related Papers
Loss of Suppressor of Cytokine Signaling 1 in Helper T Cells Leads to Defective Th17 Differentiation by Enhancing Antagonistic Effects of IFN-γ on STAT3 and Smads
|The Journal of Immunology|2008|183
Regulation of Pathogenic T Helper 17 Cell Differentiation by Steroid Receptor Coactivator-3
|Cell Reports|2018|40
A phase I clinical trial of RNF43 peptide-related immune cell therapy combined with low-dose cyclophosphamide in patients with advanced solid tumors
|PLoS ONE|2018|17
Bax-inhibiting peptide attenuates bleomycin-induced lung injury in mice
|Biology Open|2017|13